New hope for advanced cancer: first human trial of ARC101 begins
NCT ID NCT06672185
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 24 times
Summary
This early-stage study tests a new drug, ARC101, in about 70 people with advanced solid tumors that have not responded to other treatments. The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that the drug shrinks tumors. Participants must have a specific marker (Claudin 6) on their cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer Research Centre
RECRUITINGVancouver, British Columbia, V5Z 0B4, Canada
Contact
-
Cabrini Health Research
RECRUITINGMalvern, Victoria, 3144, Australia
Contact
-
Cancer Research SA
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
-
McGill University Health Centre
RECRUITINGMontreal, Quebec, H4A 0B1, Canada
Contact
-
Rambam Medical Center
RECRUITINGHaifa, 3109601, Israel
Contact
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
Contact
-
START San Antonio, LLC.
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
-
Sheba Medical Center
RECRUITINGRamat Gan, 52621, Israel
Contact
-
Sourasky Medical Center
RECRUITINGTel Aviv, 6423906, Israel
Contact
-
Sunshine Coast University Private Hospital
RECRUITINGBirtinya, Queensland, 4575, Australia
Contact
-
The Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2C4, Canada
Contact
Conditions
Explore the condition pages connected to this study.